VANCOUVER, BC / ACCESS Newswire / November 13, 2025 / Faraday Copper Corp. ("Faraday" or the "Company") announces its financial results for the three and nine months ended September 30, ...

FDA Alignment -- BioAtla ( BCAB 4.08%) achieved FDA alignment on phase three trial design, dosing, comparator, and endpoints ...

A tailored approach with rapid needs assessment before and during implementation to address local testing site barriers in ...

TORONTO, Nov. 12, 2025 /CNW/ - i-80 GOLD CORP. (TSX: IAU) (NYSE American: IAUX) ("i-80 Gold" or the "Company") reports its operating and financial results for the three and nine months ended September ...

PRNewswire/ - i-80 GOLD CORP. (TSX: IAU) (NYSE American: IAUX) ("i-80 Gold" or the "Company") reports its operating and financial results for the three and nine months ended September 30, 2025, ...

Q3 2025 Management View CEO Jean-Pierre Sommadossi reported "significant progress and achievements" this quarter, ...

Continued advancement toward Phase 2/3 clinical trial initiation, on track for the first half of 2026New preclinical data demonstrated SIL204’s ...